Home
NMRA
NMRA News

Latest Neumora Therapeutics Inc. (NMRA) News on July 7, 2025

Undervalued Opportunities: 3 Penny Stocks With Market Caps Above $30M

Simply Wall St.

a month ago

Undervalued Opportunities: 3 Penny Stocks With Market Caps Above $30M

GuruFocus.com

2 months ago

Neumora Therapeutics Inc (NMRA) Q1 2025 Earnings Call Highlights: Advancing Brain Disease ...

Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

2 months ago

Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Will Neumora Therapeutics (NASDAQ:NMRA) Spend Its Cash Wisely?

Simply Wall St.

2 months ago

Will Neumora Therapeutics (NASDAQ:NMRA) Spend Its Cash Wisely?

Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

GlobeNewswire

2 months ago

Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

Former Neumora CEO to lead Galapagos spinout

BioPharma Dive

3 months ago

Former Neumora CEO to lead Galapagos spinout

MT Newswires

4 months ago

William Blair Downgrades Neumora Therapeutics to Market Perform From Outperform

JNJ Halts Development of Depression Drug Over Efficacy Concerns

Zacks

4 months ago

JNJ Halts Development of Depression Drug Over Efficacy Concerns

J&J drops Phase III MDD programme due to lack of efficacy

Clinical Trials Arena

4 months ago

J&J drops Phase III MDD programme due to lack of efficacy

MT Newswires

4 months ago

Stifel Downgrades Neumora Therapeutics to Hold From Buy, Adjusts Price Target to $2 From $6

J&J scraps depression testing for potential blockbuster drug

BioPharma Dive

4 months ago

J&J scraps depression testing for potential blockbuster drug

Neumora Therapeutics to Present at Leerink Global Healthcare Conference

GlobeNewswire

4 months ago

Neumora Therapeutics to Present at Leerink Global Healthcare Conference

Neumora bids farewell to R&D head; Biohaven’s ‘one step forward, one step back’ data

BioPharma Dive

4 months ago

Neumora bids farewell to R&D head; Biohaven’s ‘one step forward, one step back’ data

MT Newswires

4 months ago

Stifel Adjusts Price Target on Neumora Therapeutics to $6 From $26, Maintains Buy Rating

Neumora Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire

4 months ago

Neumora Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

MT Newswires

4 months ago

Mizuho Securities Adjusts Neumora Therapeutics Price Target to $4 From $20, Maintains Outperform Rating

3 US Penny Stocks With Market Caps Below $400M

Simply Wall St.

5 months ago

3 US Penny Stocks With Market Caps Below $400M

Neumora shakes up its C-suite; Biogen cuts early-stage pipeline

BioPharma Dive

5 months ago

Neumora shakes up its C-suite; Biogen cuts early-stage pipeline

MT Newswires

5 months ago

Neumora Therapeutics Names Paul Berns as CEO, Michael Milligan as CFO

Neumora Therapeutics Announces Leadership Transition

GlobeNewswire

5 months ago

Neumora Therapeutics Announces Leadership Transition

3 US Penny Stocks With Market Caps Over $30M To Watch

Simply Wall St.

6 months ago

3 US Penny Stocks With Market Caps Over $30M To Watch

Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More

Zacks

6 months ago

Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More

Neumora shares look oversold after 80% drop, says Mizuho

TipRanks

6 months ago

Neumora shares look oversold after 80% drop, says Mizuho

MT Newswires

6 months ago

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT Newswires

6 months ago

Sector Update: Health Care Stocks Higher Friday Afternoon

MT Newswires

6 months ago

Neumora Has 2 More Chances With Navacaprant After Readout Miss, Mizuho Says

Neumora Stock Hits Record Low on Depression Drug Study Failure

Zacks

6 months ago

Neumora Stock Hits Record Low on Depression Drug Study Failure

Neumora Therapeutics’ navacaprant did not meet primary endpoint in depression

TipRanks

6 months ago

Neumora Therapeutics’ navacaprant did not meet primary endpoint in depression

Results are in for a new depression drug trial, and they're cratering this stock

Quartz

6 months ago

Results are in for a new depression drug trial, and they're cratering this stock

MT Newswires

6 months ago

Sector Update: Health Care Stocks Ease Thursday Afternoon

MT Newswires

6 months ago

Top Midday Decliners

Neumora Nosedives 80% At Pre-Market on Failed Depression Drug Trial

Insider Monkey

6 months ago

Neumora Nosedives 80% At Pre-Market on Failed Depression Drug Trial

Neumora shares sink following Phase III flop in MDD

Pharmaceutical Technology

6 months ago

Neumora shares sink following Phase III flop in MDD

MT Newswires

6 months ago

--RBC Downgrades Neumora Therapeutics to Sector Perform From Outperform, Price Target is $4

Neumora Therapeutics Stock Crashes 83% After Depression Drug Flops

Investor's Business Daily

6 months ago

Neumora Therapeutics Stock Crashes 83% After Depression Drug Flops

MT Newswires

6 months ago

Sector Update: Health Care

Neumora Therapeutics Depression Drug Fails In First Of Three Pivotal Phase 3 Trials

Benzinga

6 months ago

Neumora Therapeutics Depression Drug Fails In First Of Three Pivotal Phase 3 Trials

Neumora Plunges After Depression Drug Fails in Final-Stage Study

Bloomberg

6 months ago

Neumora Plunges After Depression Drug Fails in Final-Stage Study

MT Newswires

6 months ago

Neumora Therapeutics' Phase 3 Trial of Navacaprant in Major Depressive Disorder Fails to Meet Primary Endpoint; Shares Plunge

Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder

GlobeNewswire

6 months ago

Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder

Neumora Therapeutics, Inc. (NMRA): This Small-Cap Stock Is Ready To Explode

Insider Monkey

8 months ago

Neumora Therapeutics, Inc. (NMRA): This Small-Cap Stock Is Ready To Explode

MT Newswires

8 months ago

Neumora Therapeutics Q3 Loss Narrows

Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

8 months ago

Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Neumora Therapeutics to Participate in Upcoming Conferences in November

GlobeNewswire

8 months ago

Neumora Therapeutics to Participate in Upcoming Conferences in November

MT Newswires

8 months ago

JPMorgan Downgrades Neumora Therapeutics to Neutral, $15 Price Target

Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

GlobeNewswire

8 months ago

Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

MT Newswires

9 months ago

Neumora Therapeutics Insider Sold Shares Worth $370,962, According to a Recent SEC Filing

Neumora Therapeutics (NASDAQ:NMRA) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

9 months ago

Neumora Therapeutics (NASDAQ:NMRA) Is In A Good Position To Deliver On Growth Plans

Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders

GlobeNewswire

a year ago

Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders

MT Newswires

a year ago

Neumora Therapeutics Shares Decline After Q2 Results

Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

MT Newswires

a year ago

Needham Initiates Neumora Therapeutics With Buy Rating, $23 Price Target

MT Newswires

a year ago

Mizuho Securities Initiates Neumora Therapeutics at Outperform With $20 Price Target

10 clinical trials to watch in the second half of 2024

BioPharma Dive

a year ago

10 clinical trials to watch in the second half of 2024

Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer’s Disease Agitation

GlobeNewswire

a year ago

Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer’s Disease Agitation

This Neumora Therapeutics Insider Increased Their Holding In The Last Year

Simply Wall St.

a year ago

This Neumora Therapeutics Insider Increased Their Holding In The Last Year

MT Newswires

a year ago

Neumora Therapeutics Begins Phase 2 Study of Navacaprant in Bipolar Depression

Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression

GlobeNewswire

a year ago

Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression

MT Newswires

a year ago

Neumora Therapeutics Shares Fall as Q1 Loss Narrows

Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Neumora Therapeutics to Participate in Upcoming Conferences in May

GlobeNewswire

a year ago

Neumora Therapeutics to Participate in Upcoming Conferences in May

We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely

Simply Wall St.

a year ago

We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely

Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success

Zacks

a year ago

Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success

Neumora (NMRA) Down on FDA Clinical Hold on Neurology Drug

Zacks

a year ago

Neumora (NMRA) Down on FDA Clinical Hold on Neurology Drug

Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug

Investor's Business Daily

a year ago

Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug

Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday?

Benzinga

a year ago

Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday?

Neumora’s schizophrenia drug hit with clinical hold

BioPharma Dive

a year ago

Neumora’s schizophrenia drug hit with clinical hold

Reuters

a year ago

U.S. FDA places clinical hold on Neumora's schizophrenia drug study

Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study

GlobeNewswire

a year ago

Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study

institutional investors of Neumora Therapeutics, Inc. (NASDAQ:NMRA) must be disappointed after last week's 20% drop

Simply Wall St.

a year ago

institutional investors of Neumora Therapeutics, Inc. (NASDAQ:NMRA) must be disappointed after last week's 20% drop

Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days

GlobeNewswire

a year ago

Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days

Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Google releases GenAI tools for music creation

TechCrunch

a year ago

Google releases GenAI tools for music creation

Encore Wire (WIRE) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Zacks

a year ago

Encore Wire (WIRE) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Teladoc (TDOC) Stock Moves -1.57%: What You Should Know

Zacks

a year ago

Teladoc (TDOC) Stock Moves -1.57%: What You Should Know

Reuters

a year ago

Biden's job approval drops to 38% as border worries rise - Reuters/Ipsos

A Massive Problem With Apple Stock Today

Motley Fool

a year ago

A Massive Problem With Apple Stock Today

ITRI vs. AME: Which Stock Is the Better Value Option?

Zacks

a year ago

ITRI vs. AME: Which Stock Is the Better Value Option?

Jim Cramer is Bullish on These 10 Stocks

Insider Monkey

a year ago

Jim Cramer is Bullish on These 10 Stocks

Atkore Inc. Initiates Quarterly Dividend

Business Wire

a year ago

Atkore Inc. Initiates Quarterly Dividend

Business Wire

a year ago

Dillard’s, Citi and Mastercard Announce New Credit Card Agreements

25 Best Dividend Growth Stocks to Buy and Hold in 2024

Insider Monkey

a year ago

25 Best Dividend Growth Stocks to Buy and Hold in 2024

The S&P 500 Just Hit an All-Time High. Here's 1 Artificial Intelligence (AI) Stock to Buy and Hold Hand Over Fist.

Motley Fool

a year ago

The S&P 500 Just Hit an All-Time High. Here's 1 Artificial Intelligence (AI) Stock to Buy and Hold Hand Over Fist.

First Hawaiian, Inc. (NASDAQ:FHB) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

First Hawaiian, Inc. (NASDAQ:FHB) Q4 2023 Earnings Call Transcript

Innovative Industrial Properties (IIPR) Gains As Market Dips: What You Should Know

Zacks

a year ago

Innovative Industrial Properties (IIPR) Gains As Market Dips: What You Should Know

INTERCORP FINANCIAL SERVICES, INC. TO HOST FOURTH QUARTER 2023 EARNINGS CONFERENCE CALL & VIDEO WEBCAST PRESENTATION

PR Newswire

a year ago

INTERCORP FINANCIAL SERVICES, INC. TO HOST FOURTH QUARTER 2023 EARNINGS CONFERENCE CALL & VIDEO WEBCAST PRESENTATION

Thomson Reuters StreetEvents

a year ago

Q4 2023 Cathay General Bancorp Earnings Call

7 Battery Stocks to Turn $100,000 Into $1 Million: January 2024

InvestorPlace

a year ago

7 Battery Stocks to Turn $100,000 Into $1 Million: January 2024

GuruFocus.com

a year ago

Cathay General Bancorp (CATY) Reports Full Year and Q4 2023 Earnings

Associated Press Finance

a year ago

Cathay: Q4 Earnings Snapshot

Cathay General Bancorp Announces Fourth Quarter and Full Year 2023 Results

Business Wire

a year ago

Cathay General Bancorp Announces Fourth Quarter and Full Year 2023 Results

5 Top Stocks to Gain as Consumer Confidence Buoys Up

Zacks

a year ago

5 Top Stocks to Gain as Consumer Confidence Buoys Up

Business Wire

a year ago

Dillard’s to Donate more than $245,000 to local RMHC Chapters through sale of Southern Living Christmas Cookbook

Associated Press Finance

a year ago

United Community Banks: Q4 Earnings Snapshot

United Community Banks, Inc. Reports Fourth Quarter Results

GlobeNewswire

a year ago

United Community Banks, Inc. Reports Fourth Quarter Results

Unlocking Q4 Potential of United Community Banks (UCBI): Exploring Wall Street Estimates for Key Metrics

Zacks

a year ago

Unlocking Q4 Potential of United Community Banks (UCBI): Exploring Wall Street Estimates for Key Metrics

Should You Buy United Community Banks (UCBI) Ahead of Earnings?

Zacks

a year ago

Should You Buy United Community Banks (UCBI) Ahead of Earnings?

Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer

GlobeNewswire

a year ago

Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer

The Zacks Analyst Blog Highlights Carrols Restaurant, Shake Shack, Arcos Dorados, Chipotle Mexican Grill and Darden Restaurants

Zacks

a year ago

The Zacks Analyst Blog Highlights Carrols Restaurant, Shake Shack, Arcos Dorados, Chipotle Mexican Grill and Darden Restaurants

Department Store Stocks Q3 Highlights: Nordstrom (NYSE:JWN)

StockStory

a year ago

Department Store Stocks Q3 Highlights: Nordstrom (NYSE:JWN)

Share on Social Networks: